Pharmaceutical development is the process of identifying and assessing the procedures required to turn an active pharmaceutical component into a drug product that is appropriate for the use for which it is intended. This will be for small-scale production of a product to be utilised in clinical trials in the early phases of medication development. In order to be appropriate for production on a commercial scale, the method will have to be modified and enhanced if the tests are successful. Measuring the characteristics of the drug material and determining the essential qualities of the desired medication product are the first steps in the pharmaceutical development process. This procedure will involve determining the drug's stability and absorption characteristics as well as the best route of delivery (oral, parenteral or for local administration). It is crucial to match the qualities of the drug material with the formulation required to achieve the clinical and commercial profile. Drug substance characteristics may significantly restrict the types of formulations that may be employed and necessitate in-depth research to fulfil the necessary profile. In order to create a successful commercial product, pharmaceutical development of the drug substance, the drug product, and its manufacturing behaviour are required if the drug application is successful. The finished product needs to be secure, dependable, and efficient.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico